Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

NEORAL DIN 02237671

Status: Marketed
Holder: NOVARTIS PHARMACEUTICALS CANADA INC
Molecule: CYCLOSPORINE
Available to quote

Health Canada record

Active ingredient(s)CYCLOSPORINE 10 MG
Dosage formCapsule
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCL04AD01 CICLOSPORIN
Original market date02-Oct-1998
Current status date02-Oct-1998
SourceHealth Canada DPD

Establishment licence of the holder

Novartis Pharmaceuticals Canada Inc — licence 100273, currently licensed, last inspection rating C (2025-01-14).

Canadian shortage reports

StatusReasonEstimated resolutionTierUpdated
anticipated10MG2026-09-04

Other Canadian products containing CYCLOSPORINE

DINProductCompanyFormStrengthStatus
02282062ATOPICAELANCO CANADA LIMITEDCapsuleCYCLOSPORINE 50 MGMarketed
02282054ATOPICAELANCO CANADA LIMITEDCapsuleCYCLOSPORINE 25 MGMarketed
02282046ATOPICAELANCO CANADA LIMITEDCapsuleCYCLOSPORINE 10 MGMarketed
02282070ATOPICAELANCO CANADA LIMITEDCapsuleCYCLOSPORINE 100 MGMarketed
02382490ATOPICA FOR CATSELANCO CANADA LIMITEDSolutionCYCLOSPORINE 100 MGMarketed
02512629CEQUASUN PHARMACEUTICAL INDUSTRIES LIMITEDSolutionCYCLOSPORINE 0.09 %Marketed
02150697NEORALNOVARTIS PHARMACEUTICALS CANADA INCSolutionCYCLOSPORINE 100 MGMarketed
02150689NEORALNOVARTIS PHARMACEUTICALS CANADA INCCapsuleCYCLOSPORINE 25 MGMarketed
02150670NEORALNOVARTIS PHARMACEUTICALS CANADA INCCapsuleCYCLOSPORINE 100 MGMarketed
02150662NEORALNOVARTIS PHARMACEUTICALS CANADA INCCapsuleCYCLOSPORINE 50 MGMarketed
02142155OPTIMMUNEINTERVET CANADA CORPOintmentCYCLOSPORINE 2 MGMarketed
02355655RESTASISABBVIE CORPORATIONEmulsionCYCLOSPORINE 0.05 %Marketed
02476835RESTASIS MULTIDOSEABBVIE CORPORATIONEmulsionCYCLOSPORINE 0.05 %Marketed
00593257SANDIMMUNE I.V.NOVARTIS PHARMACEUTICALS CANADA INCSolutionCYCLOSPORINE 50 MGMarketed
02247074SANDOZ CYCLOSPORINESANDOZ CANADA INCORPORATEDCapsuleCYCLOSPORINE 50 MGMarketed
02247073SANDOZ CYCLOSPORINESANDOZ CANADA INCORPORATEDCapsuleCYCLOSPORINE 25 MGMarketed
02242821SANDOZ CYCLOSPORINESANDOZ CANADA INCORPORATEDCapsuleCYCLOSPORINE 100 MGMarketed
02462486TEVA-CYCLOSPORINETEVA CANADA LIMITEDEmulsionCYCLOSPORINE 0.05 %Marketed
02484137VERKAZIAAPOTEX INCEmulsionCYCLOSPORINE 0.1 %Marketed
02244324APO-CYCLOSPORINE ORAL SOLUTIONAPOTEX INCSolutionCYCLOSPORINE 100 MGCancelled Post Market
02495813CYCLOSPORINEEDENBRIDGE PHARMACEUTICALS, LLCCapsuleCYCLOSPORINE 100 MGDormant
02495821CYCLOSPORINEEDENBRIDGE PHARMACEUTICALS, LLCCapsuleCYCLOSPORINE 50 MGDormant
02334763CYCLOSPORINESANDOZ CANADA INCORPORATEDCapsuleCYCLOSPORINE 25 MGCancelled Pre Market
02495805CYCLOSPORINEEDENBRIDGE PHARMACEUTICALS, LLCCapsuleCYCLOSPORINE 25 MGDormant
01907182SANDIMMUNE CAP 50MGSANDOZ CANADA INCCapsuleCYCLOSPORINE 50 MGCancelled Post Market
00593249SANDIMMUNE ORAL SOL 100MG/MLSANDOZ CANADA INCLiquidCYCLOSPORINE 100 MGCancelled Post Market
00755605SANDIMMUNE SOFT GELATIN CAP 100MGSANDOZ CANADA INCCapsuleCYCLOSPORINE 100 MGCancelled Post Market
00755591SANDIMMUNE SOFT GELATINE CAP 25MGSANDOZ CANADA INCCapsuleCYCLOSPORINE 25 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
27891998-03-30Supplement to a New Drug Submission (SNDS)NEW STRENGTH

International API supply for CYCLOSPORINE

15 active FDA Drug Master Files.

Request a quote for NEORAL

How to read a Canadian DIN record